Obesity Trial, Recruiting NCT06640179 Sponsor: University of Kansas Medical Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06640179
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who received a kidney transplant from a living or deceased donor between 3 and 5 months ago, and whose transplant doctor has given clearance to participate.
  • People of any gender, race, or ethnic background.
  • People aged 18 or older.
  • People with a Body Mass Index (BMI) above 22, as long as their total body weight does not exceed 350 pounds (the limit of the body scanning equipment used in the study).
  • People who are able to give their informed consent to take part.
  • People whose kidney transplant doctor has confirmed it is safe for them to follow a diet and exercise program and complete the study's health assessments.
  • People who are able to walk for exercise.

Who may not be able to join:

  • People who are pregnant, breastfeeding, or planning to become pregnant during the study. Female participants of childbearing age who are not using contraception, are not post-menopausal, or have not had a surgical sterilisation procedure would need to agree to use a double barrier method of contraception.
  • People who have had weight-loss (bariatric) surgery in the past.
  • People currently prescribed a medication specifically for weight loss.
  • People with a current medical condition or treatment that could affect body weight, such as diabetes, thyroid disorders, chronic liver disease, cancer, or certain digestive conditions (confirm with trial site for the full list).
  • People with certain heart conditions, including heart failure, angina, uncontrolled irregular heartbeat, previous heart attack, history of heart bypass surgery or angioplasty, or conditions requiring long-term blood-thinning medication.
  • People with a resting blood pressure of 160/100 mmHg or higher, or whose blood pressure medication has not been at a stable dose and type for at least 6 months.
  • People with an eating disorder that would make changes to diet or physical activity unsafe.
  • People with a current alcohol or substance use problem.
  • People currently being treated for a psychological condition (such as depression or bipolar disorder) who have not been on a stable medication dose for the past 12 months, or who have been hospitalised for depression within the past 5 years.
  • People who plan to move away from the study location, or whose work, personal, or travel commitments would prevent them from attending scheduled sessions and assessments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John M. Jakicic, PhD, University of Kansas Medical Center

Phone: 913-588-9078

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas Medical Center
Registry
ClinicalTrials.gov
Start date
17 December 2024
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Body Weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov